Worldwide shipping · 120+ destinationsCOA & GHS SDS with every lotMon–Sat, 09:30–18:30 IST
VAQORACHEMICALS
Impurity reference standards

Pembrolizumab impurities & reference standards

Characterised Pembrolizumab impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.

1reference materials
COAHPLC · NMR · MS on request
Reference Standard
Pembrolizumab
Pembrolizumab
CAS
1374853-91-4
Formula
C292H442N78O86S3
MW
6517.3 g/mol
VQ-033087

FAQs — Pembrolizumab impurities

Which Pembrolizumab impurities do you supply?

We list 1 Pembrolizumab-related reference materials, including process impurities, degradation products and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.

What are Pembrolizumab impurity standards used for?

They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).

Can you synthesise a Pembrolizumab impurity that is not listed?

Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.

Request Pembrolizumab impurity standards

We reply within one business day with price, pack options, lead time and documentation.

By submitting you agree to our privacy policy. We never share your details.